Two Sigma Securities’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-2,900
Closed -$304K 1570
2024
Q3
$304K Sell
2,900
-3,100
-52% -$363K 0.01% 1735
2024
Q2
$853K Sell
6,000
-3,500
-37% -$404K 0.01% 1169
2024
Q1
$1.06M Buy
9,500
+4,600
+94% +$548K 0.01% 1102
2023
Q4
$635K Buy
4,900
+300
+7% +$41.3K 0.01% 1372
2023
Q3
$750K Sell
4,600
-9,500
-67% -$1.67M 0.01% 1234
2023
Q2
$2.58M Buy
14,100
+8,800
+166% +$1.27M 0.04% 499
2023
Q1
$706K Buy
+5,300
New +$623K 0.01% 1037

Other funds holding ACLS

Two Sigma Securities's ACLS Position: Q1 2026 in Review

Two Sigma Securities sold out of Axcelis (ACLS) in Q1 2026, closing a stake of 9,333 shares — an estimated $750K sold.

Two Sigma Securities first reported a position in ACLS in Q3 2023 and held it in 4 quarters. The position peaked at $750K in Q4 2025. 377 funds tracked by Wall St. Rank hold ACLS as of Q1 2026.

  • Two Sigma Securities reported no remaining Axcelis position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Securities sold 9,333 Axcelis shares in Q1 2026, an estimated $750K.
  • Two Sigma Securities first reported a position in Axcelis in Q3 2023 and held it in 4 quarters.
  • Two Sigma Securities's Axcelis position peaked at $750K in Q4 2025.
  • 377 funds tracked by Wall St. Rank held Axcelis as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.